[HTML][HTML] European Association of Urology guidelines on renal cell carcinoma: the 2022 update
…, T Klatte, T Kuusk, TB Lam, L Marconi, T Powles… - European urology, 2022 - Elsevier
… Thomas Powles has received institutional research funding from AstraZeneca, Roche,
BMS, Exelixis, Ipsen, Merck/MSD, Novartis, Pfizer, Seattle Genetics, Merck Serono, Astellas, …
BMS, Exelixis, Ipsen, Merck/MSD, Novartis, Pfizer, Seattle Genetics, Merck Serono, Astellas, …
EAU guidelines on renal cell carcinoma: 2014 update
…, L Marconi, AS Merseburger, P Mulders, T Powles… - European urology, 2015 - Elsevier
… Thomas Powles has received grants or research support from GSK, Pfizer, Astellas, GSK,
Roche, Pfizer, and Novartis, and speaker honoraria from Novartis, Pfizer and GSK, has …
Roche, Pfizer, and Novartis, and speaker honoraria from Novartis, Pfizer and GSK, has …
Overview of the main outcomes in breast-cancer prevention trials
Background Early findings on the use of tamoxifen or raloxifene as prophylaxis against breast
cancer have been mixed; we update available data and overview the combined results. …
cancer have been mixed; we update available data and overview the combined results. …
[HTML][HTML] Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma
Background Nivolumab plus ipilimumab produced objective responses in patients with
advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus …
advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus …
[HTML][HTML] Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma
…, SY Rha, C Porta, M Eto, T Powles… - … England Journal of …, 2021 - Mass Medical Soc
Background Lenvatinib in combination with pembrolizumab or everolimus has activity against
advanced renal cell carcinoma. The efficacy of these regimens as compared with that of …
advanced renal cell carcinoma. The efficacy of these regimens as compared with that of …
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a …
JE Rosenberg, J Hoffman-Censits, T Powles… - The Lancet, 2016 - thelancet.com
Background Patients with metastatic urothelial carcinoma have few treatment options after
failure of platinum-based chemotherapy. In this trial, we assessed treatment with atezolizumab…
failure of platinum-based chemotherapy. In this trial, we assessed treatment with atezolizumab…
[HTML][HTML] Nivolumab plus cabozantinib versus sunitinib for advanced renal-cell carcinoma
TK Choueiri, T Powles, M Burotto… - … England Journal of …, 2021 - Mass Medical Soc
Background The efficacy and safety of nivolumab plus cabozantinib as compared with those
of sunitinib in the treatment of previously untreated advanced renal-cell carcinoma are not …
of sunitinib in the treatment of previously untreated advanced renal-cell carcinoma are not …
[HTML][HTML] Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma
…, DI Quinn, T Powles - … England Journal of …, 2021 - Mass Medical Soc
Background Patients with renal-cell carcinoma who undergo nephrectomy have no options
for adjuvant therapy to reduce the risk of recurrence that have high levels of supporting …
for adjuvant therapy to reduce the risk of recurrence that have high levels of supporting …
[HTML][HTML] COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
… The two-sided Welch's t test was used to compare continuous data and two-sided Fisher's
exact test was used to compare categorical data from different categories with multivariate …
exact test was used to compare categorical data from different categories with multivariate …
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial
…, D Grady, TJ Powles, JA Cauley, L Norton, T Nickelsen… - Jama, 1999 - jamanetwork.com
… total of 7705 postmenopausal women, younger than 81 (mean age, 66.5) years, with
osteoporosis, defined by the presence of vertebral fractures or a femoral neck or spine T-score of at …
osteoporosis, defined by the presence of vertebral fractures or a femoral neck or spine T-score of at …